Options exercised on two targets; Voyager eligible to receive associated development, regulatory, and commercial milestones, plus tiered royalties
With option exercise, potential to expand agreement to include capsids for up to two additional targets extends for next 18 months
https://finance.yahoo.com/news/voyager-therapeutics-receive-25-million-120000507.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.